| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anti–Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer
|
Lee, David
|
|
2004
|
4 |
3 |
p. 159-162
4 p.
|
article
|
| 2 |
Current Status of Clinical Studies for Colorectal Cancer in Taiwan
|
Chen, Li-Tzong
|
|
2004
|
4 |
3 |
p. 196-203
8 p.
|
article
|
| 3 |
Dihydopyrimidine Dehydrogenase: A Critical Molecular Biomarker for 5-Fluorouracil Toxicity
|
Chu, Edward
|
|
2004
|
4 |
3 |
p. 150-
1 p.
|
article
|
| 4 |
Dihydropyrimidine Dehydrogenase Deficiency, a Pharmacogenetic Syndrome Associated with Potentially Life-Threatening Toxicity Following 5-Fluorouracil Administration
|
Ezzeldin, Hany
|
|
2004
|
4 |
3 |
p. 181-189
9 p.
|
article
|
| 5 |
Highlights From: 40th Annual Meeting of the American Society of Clinical Oncology; New Orleans, LA June 2004
|
Lee, David
|
|
2004
|
4 |
3 |
p. 154-158
5 p.
|
article
|
| 6 |
Roles of Infusional High-Dose 5-Fluorouracil with Leucovorin in Advanced Colorectal Cancer
|
Liu, Jin-Hwang
|
|
2004
|
4 |
3 |
p. 204-205
2 p.
|
article
|
| 7 |
The Role of Pemetrexed in the Treatment of Gastrointestinal Malignancy
|
Hochster, Howard S.
|
|
2004
|
4 |
3 |
p. 190-195
6 p.
|
article
|
| 8 |
Topoisomerase I Inhibitors in the Treatment of Gastrointestinal Cancer: From Intravenous to Oral Administration
|
Kuppens, Isa E.L.M.
|
|
2004
|
4 |
3 |
p. 163-180
18 p.
|
article
|
Journal description